A Holistic Review of Oncological Drug Targets and Trajectories of Resistance in Cancer Therapy
Oncology Research · 2026 · 34 (2) · 1-10
DOI: 10.32604/or.2025.071209 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Harpreet Kaur und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India. Hauptthemen laut MEDLINE: Neoplasms, Molecular Targeted Therapy, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India.
- M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, India.
- Aurobindo Pharma, Durham, NC 27709, USA.
ORCID-Profile: Harpreet Kaur
Zitieren
APA
Kaur, H., Rana, D., Bag, S., & Singh, P. (2026). A Holistic Review of Oncological Drug Targets and Trajectories of Resistance in Cancer Therapy. Oncology Research, 34(2), 1-10. https://doi.org/10.32604/or.2025.071209
Vancouver
Kaur H, Rana D, Bag S, Singh P. A Holistic Review of Oncological Drug Targets and Trajectories of Resistance in Cancer Therapy. Oncology Research. 2026;34(2):1-10. doi:10.32604/or.2025.071209
BibTeX
@article{Kaur2026,
author = {Kaur, Harpreet and Rana, Dhrubalochan and Bag, Sowvik and Singh, Paramjeet},
title = {A Holistic Review of Oncological Drug Targets and Trajectories of Resistance in Cancer Therapy},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {2},
pages = {1--10},
doi = {10.32604/or.2025.071209}
}
EUVIMED